ZA795679B - Intramammary compositions - Google Patents

Intramammary compositions

Info

Publication number
ZA795679B
ZA795679B ZA00795679A ZA795679A ZA795679B ZA 795679 B ZA795679 B ZA 795679B ZA 00795679 A ZA00795679 A ZA 00795679A ZA 795679 A ZA795679 A ZA 795679A ZA 795679 B ZA795679 B ZA 795679B
Authority
ZA
South Africa
Prior art keywords
intramammary
compositions
intramammary compositions
Prior art date
Application number
ZA00795679A
Other languages
English (en)
Inventor
J Dowrick
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of ZA795679B publication Critical patent/ZA795679B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA00795679A 1978-10-27 1979-10-24 Intramammary compositions ZA795679B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7842336 1978-10-27

Publications (1)

Publication Number Publication Date
ZA795679B true ZA795679B (en) 1980-10-29

Family

ID=10500661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00795679A ZA795679B (en) 1978-10-27 1979-10-24 Intramammary compositions

Country Status (10)

Country Link
US (2) US4282202A (xx)
EP (1) EP0010904B1 (xx)
JP (1) JPS5559108A (xx)
AU (1) AU524193B2 (xx)
CA (1) CA1121724A (xx)
DE (1) DE2962727D1 (xx)
IE (1) IE48976B1 (xx)
IL (1) IL58461A0 (xx)
NZ (1) NZ191910A (xx)
ZA (1) ZA795679B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB2119649B (en) * 1982-05-12 1986-02-12 Beecham Group Plc Ophthalmic cloxacillin compositions
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
AR004510A1 (es) 1995-09-07 1998-12-16 Smithkline Beecham Plc Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
GB9818927D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Pharmaceutical formulation
NL1014915C2 (nl) * 1999-04-13 2001-02-12 Beecham Pharm Pte Ltd Nieuwe behandelingsmethode.
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
US20090005448A1 (en) * 2005-01-19 2009-01-01 Nippon Zenyaku Kogyo Co., Ltd Injection for Mastitis
CA2661576A1 (en) * 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
CN101406450B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方阿莫西林油混悬注射液制备工艺
US20090247575A1 (en) * 2008-03-26 2009-10-01 Taro Pharmaceuticals North America, Inc. Stabilizing lipid compositions for oral pharmaceutical agents
PL2819699T3 (pl) 2012-02-27 2019-11-29 Bayer New Zealand Ltd Kompozycje o kontrolowanym uwalnianiu i sposoby ich zastosowania

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914443A (en) * 1958-03-31 1959-11-24 Abbott Lab Ointment
CA758049A (en) * 1960-07-19 1967-05-02 The Gillette Company Heat-generating cosmetic composition
US3234028A (en) * 1961-09-20 1966-02-08 Union Carbide Corp Process for banana ripening
US3302995A (en) * 1963-05-01 1967-02-07 Thomas D Oulton Synthetic swelling lithium aluminum silicate hydrate product
US4000254A (en) * 1966-04-25 1976-12-28 Schmid Laboratories, Inc. Fungimycin compositions
US4064230A (en) * 1966-04-25 1977-12-20 Schmid Laboratories, Inc. Polyenic macrolide compositions
US3733403A (en) * 1970-01-26 1973-05-15 Squibb & Sons Inc Gelled mineral oil
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
US3923969A (en) * 1973-06-12 1975-12-02 Battelle Institut E V Carrier system for a drug with sustained release
US4145429A (en) * 1974-09-21 1979-03-20 Beecham Group Limited Oral veterinary preparations
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US3998973A (en) * 1975-04-07 1976-12-21 R. T. Vanderbilt Company, Inc. Thickening composition
US4071374A (en) * 1975-06-23 1978-01-31 Gripsin Industries, Inc. Friction cosmetic gel
GB1547164A (en) * 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
GB1561592A (en) * 1976-05-05 1980-02-27 Beecham Group Ltd Antibacterial composition
JPS5325005A (en) * 1976-08-19 1978-03-08 Marutai Doboku Kk Method of driving steellpipe pile
DE2654709B2 (de) * 1976-12-02 1980-07-24 A.H. Robins Co., Inc., Richmond, Va. (V.St.A.) Verfahren zum Stabilisieren von Baldrianextraktpräparaten

Also Published As

Publication number Publication date
EP0010904A3 (en) 1980-07-23
US4282202A (en) 1981-08-04
IE48976B1 (en) 1985-06-26
EP0010904A2 (en) 1980-05-14
USRE31301E (en) 1983-07-05
IL58461A0 (en) 1980-01-31
CA1121724A (en) 1982-04-13
JPS5559108A (en) 1980-05-02
EP0010904B1 (en) 1982-05-05
AU5200879A (en) 1980-05-01
AU524193B2 (en) 1982-09-02
DE2962727D1 (en) 1982-06-24
NZ191910A (en) 1982-02-23
JPH0223530B2 (xx) 1990-05-24

Similar Documents

Publication Publication Date Title
JPS54155292A (en) Photoopolymerizable composition
JPS5571734A (en) Composition
JPS5523187A (en) Photoohardening composition
JPS54158452A (en) Composition
JPS54109654A (en) Improvement regarding composition
ZA795679B (en) Intramammary compositions
JPS5580451A (en) Composition
JPS54139654A (en) Composition
JPS5523186A (en) Photoohardening composition
JPS5571653A (en) Cement based composition
GB2021610B (en) Antianginal composition
ZA795680B (en) Intramammary compositions
JPS54152038A (en) Flameeproof*lowwsmoke hottmelt composition
JPS54107993A (en) Alphaacyanoacrylate composition
JPS54147931A (en) Antiiulcer composition
JPS54122228A (en) Novel composition
KE3426A (en) Etomidate-containing compositions
GR64830B (en) Disinfectaut composition
PT69935A (en) Insecticidals compositions
GB2020267B (en) Cement composition
JPS54116026A (en) Cement composition
JPS54147934A (en) Antiiangina composition
ZA793302B (en) Fasciolicidal compositions
PT69225A (en) Compositions
PT70100A (en) Farmaceutical compositions